• No results found

University of Groningen Multiple aspects of a plasma cell dyscrasia de Waal, Elisabeth Geertruida Maria

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Multiple aspects of a plasma cell dyscrasia de Waal, Elisabeth Geertruida Maria"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Multiple aspects of a plasma cell dyscrasia

de Waal, Elisabeth Geertruida Maria

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

de Waal, E. G. M. (2018). Multiple aspects of a plasma cell dyscrasia. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Stellingen behorend bij het proefschrift

Multiple aspects of plasma cell dyscrasia

1

Nuclear imaging enables targeting the specific cellular properties of malignant plasma cells (dit proefschrift)

2

Combination therapy with bortezomib, continuous low-dose cyclophosphamide and dexamethasone, followed by one-year maintenance therapy, is an effective and

manageable regimen for patients with relapsing MM (dit proefschrift)

3

Physicians should be aware of venous thrombotic risk in all multiple myeloma patients and tailor thrombophophylaxis to treatment regimens and patient characteristics

(dit proefschrift) 4

Patients with a solitary bone plasmacytoma following local radiotherapy are at higher risk of developing multiple myeloma, indicating that this group may benefit from added

systemic chemotherapy (dit proefschrift)

5

Dure geneesmiddelen; Er is gedoe over de prijs, niet over de kosten (Prof dr WNJ Groot)

6

A little progress each day adds up to big results 7

Prolongation of overall survival in multiple myeloma is almost always associated with prolonged progression free survival, but not the other way around

(SV Rajkumar et al, Blood. 2011;118:3205-3211) 8

Geen gejank. Een ui eerst even in koud water of in de vriezer leggen en dan pas gaan snijden. Dat bespaart een tranendal

(Enkhuizer Almanak. 2018, 423ste jaargang) 9

The doctors I admire most are characterized not by how much they know but by a sophisticated intuition about how best to share it

(L Rosenbaum, NEJM. 2015;373:589-592) 10

Koester de liefde. Maak er je grootste veldtocht van, je enige ambitie (Joël Dicker, De waarheid over de zaak Harry Quebert)

Referenties

GERELATEERDE DOCUMENTEN

in a larger number of patients, including relapsing MM patients. An additional player in fatty acid metabolism is choline, which is phosphorylated by choline kinase and

In summary the results demonstrate that [18F]-FDG-PET is more valuable than skeletal survey and SRS to detect disease activity in relapsing multiple myeloma.. Conflict of

In addition 1-α-D: -(5-deoxy-5- [18F]-fluoroarabinofuranosyl)-2-nitroimidazole ([18F]-FAZA) scan and immunohistochemical staining on bone marrow was performed to define whether

In the present study, we determined the feasibility of combination therapy in relapsing bortezomib-naïve myeloma patients using bortezomib, dexamethasone and low

VTE risk did not differ significantly according to first line treatment (IMiD 16%, non-IMiD 12%) or mode of thromboprophylaxis (aspirin 20%, low molecular weight heparin (LMWH)

In addition MVD and (neo)angiogenesis related factors were studied such as vascular endothelial growth factor (VEGF) and hypoxia inducible factors (HIF) 1α and 2α in biopsies

Transient efficacy of double high dose chemotherapy and autologous peripheral stem cell transplantation, immunoglobulin, thalidomide, and bortezomib in the treatment

If MRD positive patients show more benefit from maintenance than MRD negative patients, it will underline the need of nuclear imaging techniques for treatment monitoring.. In